Medprin Accounts Payable from 2010 to 2025

301033 Stock   48.60  0.28  0.58%   
Medprin Regenerative's Accounts Payable is increasing over the years with slightly volatile fluctuation. Accounts Payable is expected to dwindle to about 33.9 M. Accounts Payable is the amount Medprin Regenerative Medical owes to suppliers or vendors for products or services received but not yet paid for. It represents Medprin Regenerative's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
36.7 M
Current Value
33.9 M
Quarterly Volatility
7.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Medprin Regenerative financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medprin Regenerative's main balance sheet or income statement drivers, such as Tax Provision of 6.1 M, Interest Income of 2.3 M or Selling General Administrative of 39.6 M, as well as many indicators such as . Medprin financial statements analysis is a perfect complement when working with Medprin Regenerative Valuation or Volatility modules.
  
This module can also supplement various Medprin Regenerative Technical models . Check out the analysis of Medprin Regenerative Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Medprin Stock

Medprin Regenerative financial ratios help investors to determine whether Medprin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medprin with respect to the benefits of owning Medprin Regenerative security.